Fluvirin

SKU: FLUVIRIN-N Category: Tag:

Description

Fluvirin is a trivalent, sub-unit (purified surface antigen) Influenza virus vaccine indicated for active immunization against Influenza disease caused by Influenza virus subtype A and subtype B contained in the vaccine. It is licensed for use in persons 4 years of age and older. FLUVIRIN has been standardized according to  the 2016- 2017 influenza season and contains the currently circulating 3 viruses:

  • A/Christchurch/16/2010, NIB-74 (H1N1) (an A/California/7/2009 pdm09-like virus);
  • A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus);
  • B/Brisbane/60/2008, wild type (a B/Brisbane/60/2008-like virus).
The 0.5-mL prefilled syringe presentation does not contain any preservative. The 5-mL multidose vial formulation contains thimerosal, a mercury derivative, added as a preservative.

Immunization guideline:

  • Children 4 years through 8 years should receive one or two doses of 0.5 mL each of Fluvirin depending on their previous vaccination history. 2 doses should be administered at least 1 month apart
  • 9 years and older should receive one dose of 0.5 mL Fluvirin

Annual revaccination with the current vaccine is recommended because immunity declines during the year after vaccination, and also circulating strains of Influenza virus change from year to year.

For latest IAP updates see revised immunization schedule.

Additional information

vaccine-type

Influenza A vaccine (seasonal)-inactivated

manufacturer

Novartis

country-of-manufacture

United Kingdom

pharmaceutical-form

Liquid

package-size

10 Dose

route-of-administration

Intramuscular

preservative

Thiomersal

Contraindications

History of severe allergic reactions (e.g., anaphylaxis) to egg proteins, or any component of FLUVIRIN or life-threatening reactions to previous influenza vaccinations.

Get FREE personalised Vaccination Chart and SMS reminders

Start Now